Subject: WallStreet-NEWS - Med Stock on the Frontline Against AIDS and Hepatitis C, Tue, 23 Mar 2004 22:01:10 -0500
From: Lon Washburn (creawan_AT_fairyqueen.com)
Date: Wed Mar 24 2004 - 05:01:10 EET
New Wall Street - The Leading Over-the-Counter Publisher
Needle Pricks Key Danger to Doctors and Nurses
AIDS and Hepatitis C
Today, AIDS and Hepatitis C are an important concern for doctors and nurses in the operating room, the emergency room and all over the hospital, especially when handling any type of contaminated needles. Suture needles account for a whopping 40% of all needle sticks, a very dangerous environment for doctors and nurses.
20 Million people worldwide have died from AIDS.
40 million people are infected with HIV outside the U.S.
25% of all HIV infected Americans don't even know they have it.
4 million people in the U.S alone have Hepatitis C.
SutureMate - The Solution
The Suture Mate is designed to facilitate the safe handling of sharp medical instruments as mandated by OSHA Directive CPL 2-244D and the federal Needle-stick Safety Act.
Designed and developed by Dr. Michael Swor, MD, it is a disposable surgical device that has been clinically proven to reduce glove perforations by 60-80%, and percutaneous injuries by 70%. In other words this surgical devise helps prevent the transference of these highly contagious diseases.
Recent news will add millions to bottom line.
Power3 Medical's SutureMate to Obtain CE Mark Required for Sales In European Marketplace.
BRADENTON, Fla., (PRIMEZONE via COMTEX) -- Power3 Medical Products, Inc. (OTCBB: PWRM) announces that they are in the final process of obtaining CE product designation required to initiate International sales of their SutureMate(r) product. The CE Mark is a requirement which products must meet in order to be sold in the European market, including stringent safety and performance requirements
Management projects, with the new CE and International marketing efforts taking place, that SutureMate utilization and international sales will grow to 50,000 units per month by year’s end 2004, resulting in gross revenues exceeding two million dollars per year for this product line.
New Wall Street (NWS) is not a registered financial advisory. The information presented by NWS is not an offer to buy or sell securities. NWS accumulates then distributes opinions, comments and information based on other public sources. Penny stocks are considered to be highly speculative and may be unsuitable for all but very aggressive investors. NWS does not hold nor does it plan to hold a position in this stock. This Profile was a paid advertisement by a third party, not affiliated with PWRM, who has purchased 500,000 restricted shares of PWRM from the company. These shares cannot be sold in the market for one year. NWS was compensated 65,000.00 dollars to publish this report. Target prices may fluctuate depending on market environments. Please always consult a registered financial advisor before making any decisions. This report is for entertainment and advertising purposes only and should not be used as investment advice. This email distributed by SCI. SCI was paid four thousand dollars to dis
tribute this email. Apartado 0832-0588, Calle 53 Marbella Panama City, Panama.
No more ads: queightcer_AT_mailbox.co.za
bitterroot percentile purview barbudo kale auctioneer stromberg oil dorothea divergent ergative
beriberi annotate caribbean transmute crossroad capitol audiotape birdlike blood mayor drafty
This archive was generated by hypermail 2b28 : Wed Mar 24 2004 - 04:56:21 EET